Where Oscar Health Stands With Analysts
Portfolio Pulse from Benzinga Insights
Oscar Health (NYSE:OSCR) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target remains at $26.0. Analysts have maintained or raised their ratings, reflecting a stable outlook. Despite positive revenue growth, Oscar Health faces challenges with net margins but shows strong ROE and ROA.
October 07, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Oscar Health has received mixed analyst ratings, with a stable average price target of $26.0. Analysts have maintained or raised their ratings, indicating a stable outlook. The company shows strong ROE and ROA but faces challenges with net margins.
The article provides a detailed analysis of Oscar Health's recent analyst ratings, price targets, and financial metrics. The stable price target and mixed ratings suggest a neutral short-term impact on the stock price. The company's strong ROE and ROA are positive indicators, but challenges with net margins may offset these benefits.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100